Real-time enrollment status for this covid-19 clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 1:43 AM UTC
| NCT Number | NCT03808922 |
| Recruiting Status | Recruiting |
| Condition | COVID-19 |
| Phase | PHASE3 |
| Target Enrollment | 274 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Ansun Biopharma, Inc. |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT03808922 is currently recruiting participants. This phase3 study for covid-19 is actively seeking new participants at 23 locations across the United States. The study is sponsored by Ansun Biopharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03808922 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03808922 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.